Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.34 |
| ▸ | AKT1 | P31749 | 2/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | KIT | P10721 | 1/20 | 0.32 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.32 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.32 |
| ▸ | PDE2A | O00408 | 2/20 | 0.32 |
| ▸ | ERN1 | O75460 | 1/20 | 0.31 |
| ▸ | BDKRB1 | P46663 | 4/20 | 0.31 |
| ▸ | AKT2 | P31751 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34469923 | 0.94 | EGLN2 (0.33) | EGLN2AKT1CYP17A1PKMKIT | |
| SCHEMBL34470168 | 0.91 | EGLN2 (0.35) | EGLN2AKT1GSK3BDYRK1ACYP17A1 | |
| SCHEMBL34469480 | 0.86 | EGLN2 (0.34) | EGLN2AKT1GSK3BDYRK1ACYP17A1 | |
| SCHEMBL34469468 | 0.85 | AKT1 (0.43) | AKT1GSK3BDYRK1APKMKIT | |
| SCHEMBL34470005 | 0.81 | AKT1 (0.43) | AKT1GSK3BDYRK1APKMKIT | |
| SCHEMBL34469676 | 0.78 | AKT1 (0.41) | AKT1GSK3BDYRK1APKMKIT | |
| SCHEMBL34469978 | 0.76 | AKT1 (0.43) | AKT1GSK3BDYRK1AKITPDE2A | |
| SCHEMBL5517439 | 0.73 | AAK1 (0.45) | DPP8DPP9PDE2A | |
| SCHEMBL34469713 | 0.73 | AAK1 (0.45) | DPP8DPP9PDE2A | |
| SCHEMBL34470155 | 0.73 | SLC6A3 (0.47) | EGLN2ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090477-A1 | HELICASE INHIBITORS AND USES THEREOF | KIMIA THERAPEUTICS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |